Successful treatment of novel H1N1 influenza related fulminant myocarditis with extracorporeal life support

J Cardiothorac Surg. 2011 Dec 20:6:164. doi: 10.1186/1749-8090-6-164.

Abstract

The prevalence of myocardial involvement in influenza infection ranges from 0% to 12%. The 2009 pH1N1 influenza virus, formerly known as swine flu, first appeared in Mexico and the United States of America in March and April 2009 and has swept the globe with unprecedented speed. We report a case of fulminant myocarditis associated with this virus treated successfully using extra-corporal membrane oxygenator.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antiviral Agents / therapeutic use*
  • Extracorporeal Circulation / methods*
  • Female
  • Follow-Up Studies
  • Humans
  • Influenza A Virus, H1N1 Subtype / genetics
  • Influenza A Virus, H1N1 Subtype / immunology*
  • Influenza A Virus, H1N1 Subtype / isolation & purification
  • Influenza Vaccines / therapeutic use*
  • Influenza, Human / complications*
  • Influenza, Human / drug therapy
  • Influenza, Human / virology
  • Myocarditis / etiology
  • Myocarditis / therapy*
  • Myocarditis / virology
  • Oseltamivir / therapeutic use*
  • Polymerase Chain Reaction
  • RNA, Viral / analysis

Substances

  • Antiviral Agents
  • Influenza Vaccines
  • RNA, Viral
  • Oseltamivir